GLIMITERIS MV1 0.2 by Steris Healthcare — Complete Guide to Uses, Dosage & Precautions

 GLIMITERIS MV1 0.2, manufactured by Steris Healthcare, is a triple-drug combination tablet containing Glimepiride IP 1 mg, Voglibose IP 0.2 mg, and Metformin Hydrochloride IP 500 mg, prescribed for the management of Type 2 diabetes mellitus in adults whose blood glucose is not adequately controlled on diet, exercise, and single or dual-drug therapy alone. This combination addresses blood sugar control through three complementary mechanisms: Glimepiride stimulates insulin release from the pancreas, Voglibose slows carbohydrate absorption in the intestine to reduce post-meal glucose spikes, and Metformin improves insulin sensitivity while reducing hepatic glucose production. Together, they offer comprehensive glycemic control in a single, convenient tablet.

Why It's Important

Type 2 diabetes is a progressive metabolic condition, and many patients eventually require more than one class of antidiabetic medication to achieve target blood glucose levels, particularly as beta-cell function and insulin sensitivity decline over time. Relying on a single mechanism often leaves either fasting or post-meal (postprandial) glucose spikes inadequately controlled. GLIMITERIS MV1 0.2's triple-action formula addresses both fasting and postprandial glucose excursions simultaneously, which is clinically important because sustained post-meal glucose spikes are independently associated with increased cardiovascular risk. Combining three mechanisms into one tablet also reduces overall pill burden, supporting better long-term treatment adherence — a critical factor in preventing diabetes-related complications such as neuropathy, nephropathy, and retinopathy.

Key Benefits 

What are the benefits?

  • Comprehensive blood glucose control through three complementary mechanisms
  • Reduces post-meal (postprandial) glucose spikes effectively
  • Improves insulin sensitivity and reduces hepatic glucose output
  • Simplifies treatment regimen with a single combination tablet
  • Manufactured under WHO-GMP and ISO 9001:2018 certified facility standards by Steris Healthcare, ensuring consistent quality and reliability

Side Effects

Common side effects may include gastrointestinal discomfort such as bloating, flatulence, diarrhea, nausea, or a metallic taste, particularly during initial use.

Serious Side Effects 

Seek immediate medical attention for signs of hypoglycemia (sweating, shakiness, confusion, fainting), signs of lactic acidosis (unusual muscle pain, difficulty breathing, severe fatigue), or signs of an allergic reaction such as rash or swelling.

Available Substitute 

Several branded Glimepiride, Voglibose, and Metformin triple-combination formulations are available in the Indian market at comparable strengths. Brand switches should only be made under physician guidance to maintain stable glycemic control.

Dosage Guidelines 

Dosage is individualized by the treating physician based on blood glucose levels and patient response, typically taken with the first bite of a main meal to optimize glucose control and reduce gastrointestinal side effects. Regular blood glucose monitoring is recommended. Missed doses should not be doubled.

Precautions & Warnings

Use cautiously in patients with renal or hepatic impairment, and avoid use in those with a history of lactic acidosis. Alcohol should be limited, as it can increase the risk of hypoglycemia and lactic acidosis. Inform your doctor of all current medications before starting therapy.

Mechanism of Action

Glimepiride stimulates pancreatic beta-cells to release insulin. Voglibose inhibits intestinal alpha-glucosidase enzymes, slowing carbohydrate breakdown and glucose absorption. Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, together providing broad-spectrum glycemic control.

Conclusion

GLIMITERIS MV1 0.2 by Steris Healthcare offers a comprehensive, triple-action approach to Type 2 diabetes management, addressing fasting and postprandial glucose control in a single tablet. Treatment should be guided by a physician with regular monitoring for optimal long-term outcomes.

Comments

Post a Comment

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

 Healthcare is one of the most significant sectors influencing the well-being of individuals and communities. As medical science advances, the demand for reliable pharmaceutical products continues to grow. Patients, healthcare professionals, and medical institutions all depend on high-quality medicines that meet strict standards of safety and effectiveness. Pharmaceutical companies play a vital role in ensuring these products are developed, manufactured, and delivered responsibly. Steris Healthcare is committed to supporting better healthcare by providing quality pharmaceutical products designed to improve patient outcomes. Guided by innovation, integrity, and continuous improvement, the company strives to meet the evolving needs of the healthcare industry while maintaining high standards of quality and customer satisfaction. A Vision for Better Healthcare Every successful healthcare organization begins with a clear vision. Steris Healthcare believes that quality medicines and de...
Read more

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness

Image
  N-Acetyl L-Cysteine (NAC), Pine Bark Extract & Resveratrol Tablets: Ingredients and Health Benefits Today’s lifestyle in India has changed a lot. Long working hours, stress, pollution, processed food, and lack of physical activity are affecting overall health. Many people feel tired, low on energy, or struggle with metabolic and hormonal balance tablet . One of the main reasons behind this is oxidative stress. Oxidative stress happens when harmful molecules called free radicals damage the body’s cells. Over time, this may affect immunity, liver health, heart health, skin, and overall wellness.  STYLECYSTIN ENDO is a specially designed antioxidant tablet that contains N-Acetyl L-Cysteine (NAC), Pine Bark Extract, and Resveratrol . This powerful combination supports cellular protection, improves antioxidant levels, and promotes better internal balance. It is commonly recommended as supportive therapy in metabolic conditions, women’s health concerns, and lifestyle-related ...
Read more
Megestrol Acetate 160 mg: MAGRAL 160 Uses, Benefits & Safety MAGRAL 160 contains Megestrol Acetate 160 mg and is marketed by Steris Healthcare . Megestrol acetate is a synthetic progestin that is used in specific clinical situations, particularly for managing anorexia, cachexia, or significant unexplained weight loss associated with advanced cancer or AIDS , depending on the approved indication and medical judgment. It is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Megestrol acetate is not a general-purpose appetite booster or routine weight-gain medicine. Before treatment, the underlying reason for poor appetite or weight loss should be evaluated. What is MAGRAL 160 For? MAGRAL 160 may be prescribed when significant appetite loss or involuntary weight loss occurs in certain serious medical conditions. Megestrol acetate can help increase appetite and may contribute to weight gain in appropriately selected patients. Th...
Read more